# Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

> **NCT04515602** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Shanghai Gynecologic Oncology Group** · enrollment: 410 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **PROCEDURE:** Primary debulking surgery
- **PROCEDURE:** Neoadjuvant chemotherapy
- **DRUG:** PARPi

## Key facts

- **NCT ID:** NCT04515602
- **Lead sponsor:** Shanghai Gynecologic Oncology Group
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-01
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 410 (ESTIMATED)
- **Last updated:** 2020-08-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04515602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04515602, "Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04515602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*